1. First report of eribulin in combination with pertuzumab and trastuzumab for advanced HER2-positive breast cancer. (October 2017) Authors: Araki, Kazuhiro; Fukada, Ippei; Yanagi, Hiroyo; Kobayashi, Kokoro; Shibayama, Tomoko; Horii, Rie; Takahashi, Shunji; Akiyama, Futoshi; Ohno, Shinji; Ito, Yoshinori Journal: Breast Issue: Volume 35(2017) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer. Issue 5 (9th March 2022) Authors: Chin, Yoon Ming; Shibayama, Tomoko; Chan, Hiu Ting; Otaki, Masumi; Hara, Fumikata; Kobayashi, Takayuki; Kobayashi, Kokoro; Hosonaga, Mari; Fukada, Ippei; Inagaki, Lina; Ono, Makiko; Ito, Yoshinori; Takahashi, Shunji; Ohno, Shinji; Ueno, Takayuki; Nakamura, Yusuke; Low, Siew‐Kee Journal: Cancer science Issue: Volume 113:Issue 5(2022) Page Start: 1808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗